Cargando…

Efficacy of Lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study

Subthreshold depression is a highly prevalent condition in adolescents who are at high risk for developing major depressive disorder. In preclinical models of neurological and psychiatric diseases, Lycium barbarum polysaccharide (LBP) extracted from Goji berries had anti-depressant effects including...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoyue, Mo, Xuan, Liu, Tao, Shao, Robin, Teopiz, Kayla, McIntyre, Roger S., So, Kwok-Fai, Lin, Kangguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771081/
https://www.ncbi.nlm.nih.gov/pubmed/34916444
http://dx.doi.org/10.4103/1673-5374.330618
_version_ 1784635519304466432
author Li, Xiaoyue
Mo, Xuan
Liu, Tao
Shao, Robin
Teopiz, Kayla
McIntyre, Roger S.
So, Kwok-Fai
Lin, Kangguang
author_facet Li, Xiaoyue
Mo, Xuan
Liu, Tao
Shao, Robin
Teopiz, Kayla
McIntyre, Roger S.
So, Kwok-Fai
Lin, Kangguang
author_sort Li, Xiaoyue
collection PubMed
description Subthreshold depression is a highly prevalent condition in adolescents who are at high risk for developing major depressive disorder. In preclinical models of neurological and psychiatric diseases, Lycium barbarum polysaccharide (LBP) extracted from Goji berries had anti-depressant effects including but not limited to anti-oxidative and anti-inflammatory properties. However, the effect of LBP on subthreshold depression is unclear. To investigate the clinical efficacy and safety of LBP for treating subthreshold depression in adolescents, we conducted a randomized, double-blind, placebo-controlled trial (RCT) with 29 adolescents with subthreshold depression recruited at The Fifth Affiliated Hospital of Guangzhou Medical University. The participants were randomly assigned to groups where they received either 300 mg LBP (LBP group, n = 15, 3 boys and 12 girls aged 15.13 ± 2.17 years) or a placebo (placebo group, n = 14, 2 boys and 12 girls aged 15 ± 1.71 years) for 6 successive weeks. Interim analyses revealed that the LBP group exhibited a greater change in Hamilton Depression Scale (HAMD-24) scores relative to the baseline and a higher remission rate (HAMD-24 total score ≤ 7) at 6 weeks compared with the placebo group. Scores on the Beck Depression Inventory-II (BDI-II), Pittsburgh Sleep Quality Index (PSQI), Kessler Psychological Distress Scale (Kessler), and Screen for Child Anxiety-Related Emotional Disorders (SCARED) were similar between the LBP and placebo groups. No side effects related to the intervention were reported in either group. These results indicate that LBP administration reduced depressive symptoms in adolescents with subthreshold depression. Furthermore, LBP was well tolerated with no treatment-limiting adverse events. Clinical trials involving a larger sample size are needed to further confirm the anti-depressive effects of LBP in adolescents with subthreshold depression. This study was approved by the Medical Ethics Committee of the Fifth Affiliated Hospital of Guangzhou Medical University (Guangzhou, China; approval No. L2019-08) on April 4, 2019 and was registered on ClinicalTrials.gov (identifier: NCT04032795) on July 25, 2019.
format Online
Article
Text
id pubmed-8771081
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-87710812022-02-03 Efficacy of Lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study Li, Xiaoyue Mo, Xuan Liu, Tao Shao, Robin Teopiz, Kayla McIntyre, Roger S. So, Kwok-Fai Lin, Kangguang Neural Regen Res Research Article Subthreshold depression is a highly prevalent condition in adolescents who are at high risk for developing major depressive disorder. In preclinical models of neurological and psychiatric diseases, Lycium barbarum polysaccharide (LBP) extracted from Goji berries had anti-depressant effects including but not limited to anti-oxidative and anti-inflammatory properties. However, the effect of LBP on subthreshold depression is unclear. To investigate the clinical efficacy and safety of LBP for treating subthreshold depression in adolescents, we conducted a randomized, double-blind, placebo-controlled trial (RCT) with 29 adolescents with subthreshold depression recruited at The Fifth Affiliated Hospital of Guangzhou Medical University. The participants were randomly assigned to groups where they received either 300 mg LBP (LBP group, n = 15, 3 boys and 12 girls aged 15.13 ± 2.17 years) or a placebo (placebo group, n = 14, 2 boys and 12 girls aged 15 ± 1.71 years) for 6 successive weeks. Interim analyses revealed that the LBP group exhibited a greater change in Hamilton Depression Scale (HAMD-24) scores relative to the baseline and a higher remission rate (HAMD-24 total score ≤ 7) at 6 weeks compared with the placebo group. Scores on the Beck Depression Inventory-II (BDI-II), Pittsburgh Sleep Quality Index (PSQI), Kessler Psychological Distress Scale (Kessler), and Screen for Child Anxiety-Related Emotional Disorders (SCARED) were similar between the LBP and placebo groups. No side effects related to the intervention were reported in either group. These results indicate that LBP administration reduced depressive symptoms in adolescents with subthreshold depression. Furthermore, LBP was well tolerated with no treatment-limiting adverse events. Clinical trials involving a larger sample size are needed to further confirm the anti-depressive effects of LBP in adolescents with subthreshold depression. This study was approved by the Medical Ethics Committee of the Fifth Affiliated Hospital of Guangzhou Medical University (Guangzhou, China; approval No. L2019-08) on April 4, 2019 and was registered on ClinicalTrials.gov (identifier: NCT04032795) on July 25, 2019. Wolters Kluwer - Medknow 2021-12-10 /pmc/articles/PMC8771081/ /pubmed/34916444 http://dx.doi.org/10.4103/1673-5374.330618 Text en Copyright: © Neural Regeneration Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Research Article
Li, Xiaoyue
Mo, Xuan
Liu, Tao
Shao, Robin
Teopiz, Kayla
McIntyre, Roger S.
So, Kwok-Fai
Lin, Kangguang
Efficacy of Lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study
title Efficacy of Lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study
title_full Efficacy of Lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study
title_fullStr Efficacy of Lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study
title_full_unstemmed Efficacy of Lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study
title_short Efficacy of Lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study
title_sort efficacy of lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771081/
https://www.ncbi.nlm.nih.gov/pubmed/34916444
http://dx.doi.org/10.4103/1673-5374.330618
work_keys_str_mv AT lixiaoyue efficacyoflyciumbarbarumpolysaccharideinadolescentswithsubthresholddepressioninterimanalysisofarandomizedcontrolledstudy
AT moxuan efficacyoflyciumbarbarumpolysaccharideinadolescentswithsubthresholddepressioninterimanalysisofarandomizedcontrolledstudy
AT liutao efficacyoflyciumbarbarumpolysaccharideinadolescentswithsubthresholddepressioninterimanalysisofarandomizedcontrolledstudy
AT shaorobin efficacyoflyciumbarbarumpolysaccharideinadolescentswithsubthresholddepressioninterimanalysisofarandomizedcontrolledstudy
AT teopizkayla efficacyoflyciumbarbarumpolysaccharideinadolescentswithsubthresholddepressioninterimanalysisofarandomizedcontrolledstudy
AT mcintyrerogers efficacyoflyciumbarbarumpolysaccharideinadolescentswithsubthresholddepressioninterimanalysisofarandomizedcontrolledstudy
AT sokwokfai efficacyoflyciumbarbarumpolysaccharideinadolescentswithsubthresholddepressioninterimanalysisofarandomizedcontrolledstudy
AT linkangguang efficacyoflyciumbarbarumpolysaccharideinadolescentswithsubthresholddepressioninterimanalysisofarandomizedcontrolledstudy